It has been a very busy year for us and also very challenging.
We’ve responded to many requests for information about COVID-19 from anxious thyroid patients, whilst also maintaining our T3 campaign. This involved lobbying the Regional Medicines Optimisation Committee and NICE to finalise their guidance “Thyroid Disease: Assessment and Management”, which was published in November 2019.
We also published a new version of our website and continued to grow our online community.
We would like to thank you for all your support over this very challenging year and we look forward to continuing our campaigning for better treatment on your behalf in 2021.